Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
Ann Hematol. 2023 Feb;102(2):323-328. doi: 10.1007/s00277-022-05075-4. Epub 2022 Dec 28.
Ann Hematol. 2023.
PMID: 36576532
Free PMC article.
Item in Clipboard
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Shahswar R, Beutel G, Gabdoulline R, Schwarzer A, Kloos A, Koenecke C, Stadler M, Gohring G, Behrens YL, Li Z, Dallmann LK, Klement P, Albert C, Wichmann M, Alwie Y, Benner A, Saadati M, Ganser A, Thol F, Heuser M.
Shahswar R, et al. Among authors: dallmann lk.
Haematologica. 2024 Jan 1;109(1):72-83. doi: 10.3324/haematol.2023.282912.
Haematologica. 2024.
PMID: 37470150
Free PMC article.
Item in Clipboard
Cite
Cite